Arvid Carlsson - Publications

University of Göteborg, Gothenburg, Västra Götalands län, Sweden 
Monoamine neurotransmission and pharmacology

0/25 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
Low-probability matches
2014 Kloberg A, Constantinescu R, Nilsson MK, Carlsson ML, Carlsson A, Wahlström J, Haghighi S. Tolerability and efficacy of the monoaminergic stabilizer (-)-OSU6162 (PNU-96391A) in Huntington's disease: a double-blind cross-over study. Acta Neuropsychiatrica. 26: 298-306. PMID 25241758 DOI: 10.1017/neu.2014.16  0.08
2012 Johansson B, Carlsson A, Carlsson ML, Karlsson M, Nilsson MK, Nordquist-Brandt E, Rönnbäck L. Placebo-controlled cross-over study of the monoaminergic stabiliser (-)-OSU6162 in mental fatigue following stroke or traumatic brain injury. Acta Neuropsychiatrica. 24: 266-74. PMID 25286991 DOI: 10.1111/j.1601-5215.2012.00678.x  0.08
2012 Steensland P, Fredriksson I, Holst S, Feltmann K, Franck J, Schilström B, Carlsson A. The monoamine stabilizer (-)-OSU6162 attenuates voluntary ethanol intake and ethanol-induced dopamine output in nucleus accumbens. Biological Psychiatry. 72: 823-31. PMID 22817867 DOI: 10.1016/j.biopsych.2012.06.018  0.08
2011 Carlsson ML, Burstein ES, Kloberg A, Hansson S, Schedwin A, Nilsson M, Rung JP, Carlsson A. I. In vivo evidence for partial agonist effects of (-)-OSU6162 and (+)-OSU6162 on 5-HT2A serotonin receptors. Journal of Neural Transmission (Vienna, Austria : 1996). 118: 1511-22. PMID 21874578 DOI: 10.1007/s00702-011-0704-8  0.08
2011 Burstein ES, Carlsson ML, Owens M, Ma JN, Schiffer HH, Carlsson A, Hacksell U. II. In vitro evidence that (-)-OSU6162 and (+)-OSU6162 produce their behavioral effects through 5-HT2A serotonin and D2 dopamine receptors. Journal of Neural Transmission (Vienna, Austria : 1996). 118: 1523-33. PMID 21866391 DOI: 10.1007/s00702-011-0701-y  0.08
2011 Rung JP, Rung E, Johansson AM, Svensson K, Carlsson A, Carlsson ML. Effects of the dopamine stabilizers (S)-(-)-OSU6162 and ACR16 on prolactin secretion in drug-naive and monoamine-depleted rats. Naunyn-Schmiedeberg's Archives of Pharmacology. 384: 39-45. PMID 21533991 DOI: 10.1007/s00210-011-0641-y  0.08
2009 Gründer G, Hippius H, Carlsson A. The 'atypicality' of antipsychotics: a concept re-examined and re-defined. Nature Reviews. Drug Discovery. 8: 197-202. PMID 19214197 DOI: 10.1038/nrd2806  0.08
2008 Starck G, Ljungberg M, Nilsson M, Jönsson L, Lundberg S, Ivarsson T, Ribbelin S, Ekholm S, Carlsson A, Forssell-Aronsson E, Carlsson ML. A 1H magnetic resonance spectroscopy study in adults with obsessive compulsive disorder: relationship between metabolite concentrations and symptom severity. Journal of Neural Transmission (Vienna, Austria : 1996). 115: 1051-62. PMID 18528631 DOI: 10.1007/s00702-008-0045-4  0.08
2008 Carlsson A, Carlsson ML. Adaptive properties and heterogeneity of dopamine D(2) receptors - pharmacological implications. Brain Research Reviews. 58: 374-8. PMID 18511124 DOI: 10.1016/j.brainresrev.2007.09.007  0.08
2008 Rung JP, Rung E, Helgeson L, Johansson AM, Svensson K, Carlsson A, Carlsson ML. Effects of (-)-OSU6162 and ACR16 on motor activity in rats, indicating a unique mechanism of dopaminergic stabilization. Journal of Neural Transmission (Vienna, Austria : 1996). 115: 899-908. PMID 18351286 DOI: 10.1007/s00702-008-0038-3  0.08
2006 Carlsson A, Carlsson ML. A dopaminergic deficit hypothesis of schizophrenia: the path to discovery. Dialogues in Clinical Neuroscience. 8: 137-42. PMID 16640125  0.08
2005 Rung JP, Carlsson A, Rydén Markinhuhta K, Carlsson ML. (+)-MK-801 induced social withdrawal in rats; a model for negative symptoms of schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 29: 827-32. PMID 15916843 DOI: 10.1016/j.pnpbp.2005.03.004  0.08
2005 Rung JP, Carlsson A, Markinhuhta KR, Carlsson ML. The dopaminergic stabilizers (-)-OSU6162 and ACR16 reverse (+)-MK-801-induced social withdrawal in rats. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 29: 833-9. PMID 15913873 DOI: 10.1016/j.pnpbp.2005.03.003  0.08
2004 Lundberg S, Carlsson A, Norfeldt P, Carlsson ML. Nicotine treatment of obsessive-compulsive disorder. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 28: 1195-9. PMID 15610934 DOI: 10.1016/j.pnpbp.2004.06.014  0.08
2004 Nilsson M, Carlsson A, Markinhuhta KR, Sonesson C, Pettersson F, Gullme M, Carlsson ML. The dopaminergic stabiliser ACR16 counteracts the behavioural primitivization induced by the NMDA receptor antagonist MK-801 in mice: implications for cognition. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 28: 677-85. PMID 15276693 DOI: 10.1016/j.pnpbp.2004.05.004  0.08
2004 Nydén A, Carlsson M, Carlsson A, Gillberg C. Interhemispheric transfer in high-functioning children and adolescents with autism spectrum disorders: a controlled pilot study. Developmental Medicine and Child Neurology. 46: 448-54. PMID 15230457 DOI: 10.1017/S001216220400074X  0.08
2003 Grunder G, Carlsson A, Wong DF. Mechanism of new antipsychotic medications: occupancy is not just antagonism. Archives of General Psychiatry. 60: 974-7. PMID 14557141 DOI: 10.1001/archpsyc.60.10.974  0.08
2003 Gefvert O, Lindström LH, Waters N, Waters S, Carlsson A, Tedroff J. Different corticostriatal patterns of L-DOPA utilization in patients with untreated schizophrenia and patients treated with classical antipsychotics or clozapine. Scandinavian Journal of Psychology. 44: 289-92. PMID 12914593 DOI: 10.1111/1467-9450.00347  0.08
2015 Khemiri L, Steensland P, Guterstam J, Beck O, Carlsson A, Franck J, Jayaram-Lindström N. The effects of the monoamine stabilizer (-)-OSU6162 on craving in alcohol dependent individuals: A human laboratory study. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 26482910 DOI: 10.1016/j.euroneuro.2015.09.018  0.04
2021 Haghighi S, Forsmark S, Zachrisson O, Carlsson A, Nilsson MKL, Carlsson ML, Schuit RC, Gottfries CG. Open-label study with the monoamine stabilizer (-)-OSU6162 in myalgic encephalomyelitis/chronic fatigue syndrome. Brain and Behavior. e02040. PMID 33528911 DOI: 10.1002/brb3.2040  0.01
2018 Haghighi S, Forsmark S, Carlsson A, Nilsson MKL, Carlsson ML, Schuit RC, Gottfries CG. Open study with (-)-OSU6162 in multiple sclerosis-related fatigue. Acta Neurologica Scandinavica. PMID 30132786 DOI: 10.1111/ane.13007  0.01
2017 Nilsson MKL, Zachrisson O, Gottfries CG, Matousek M, Peilot B, Forsmark S, Schuit RC, Carlsson ML, Kloberg A, Carlsson A. A randomised controlled trial of the monoaminergic stabiliser (-)-OSU6162 in treatment of myalgic encephalomyelitis/chronic fatigue syndrome. Acta Neuropsychiatrica. 1-10. PMID 29212562 DOI: 10.1017/neu.2017.35  0.01
2016 Ljungberg M, Nilsson MK, Melin K, Jönsson L, Carlsson A, Carlsson Å, Forssell-Aronsson E, Ivarsson T, Carlsson M, Starck G. 1H magnetic resonance spectroscopy evidence for occipital involvement in treatment-naive paediatric obsessive-compulsive disorder. Acta Neuropsychiatrica. 1-12. PMID 27772535 DOI: 10.1017/neu.2016.52  0.01
2015 Tolboom N, Berendse HW, Leysen JE, Yaqub M, van Berckel BN, Schuit RC, Ponsen MM, Bakker E, Hoetjes NJ, Windhorst AD, Carlsson ML, Lammertsma AA, Carlsson A. The dopamine stabilizer (-)-OSU6162 occupies a subpopulation of striatal dopamine D2/D3 receptors: an [(11)C]raclopride PET study in healthy human subjects. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 472-9. PMID 25248987 DOI: 10.1038/npp.2014.195  0.01
1980 Carlsson A, Svennerholm L, Winblad B. SEASONAL AND CIRCADIAN MONOAMINE VARIATIONS IN HUMAN BRAINS EXAMINED POST MORTEM. Acta Psychiatrica Scandinavica. 61: 75-85. PMID 28678362 DOI: 10.1111/acps.1980.61.s280.75  0.01
Hide low-probability matches.